Kidney health may change how drug works in body
NCT ID NCT07165015
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at how the drug LY3537031 moves through the body in people with different levels of kidney function. It included 31 adults with normal kidneys, kidney impairment, or end-stage kidney disease. The goal was to measure drug levels in the blood and how long it takes to leave the body, not to treat any condition.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for END STAGE RENAL DISEASE (ESRD) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Indiana University School of Medicine
Indianapolis, Indiana, 46202-5188, United States
-
New Zealand Clinical Research Christchurch
Christchurch, New Zealand
-
Omega Research Orlando LLC
Orlando, Florida, 32808, United States
-
Orlando Clinical Research Center
Orlando, Florida, 32809, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a new oral drug change future treatments? early safety trial begins
- Can brain scans unlock the secret to hearing in crowded rooms?
- Can a Light-Guided device make arterial sticks easier?
- A simple baking soda pill may protect dialysis Patients' blood vessels
- Water workouts could be the key to back pain relief
- Could everyday disinfectants be harming us? a new study investigates